Inhibitions of monoamine oxidases by ferulic acid hydrazide derivatives: synthesis, biochemistry, and computational evaluation
Abstract Monoamine oxidases (MAOs) regulate neurotransmitters, and changes in their regulation lead to neurogenerative diseases (NDs). Therefore, MAO inhibitors are used to treat NDs. Ferulic acid, a phenolic compound found in various plant species, has been demonstrated to have a variety of biologi...
Main Authors: | Arshida Thottile Peedikayil, Jiseong Lee, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Mohamed E. Shaker, Samy Selim, Sunil Kumar, Sanal Dev, Hoon Kim, Bijo Mathew |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2023-10-01
|
Series: | Applied Biological Chemistry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13765-023-00823-0 |
Similar Items
-
<i>N</i>-Hydroxy-<i>N</i>-Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases
by: Óscar M. Bautista-Aguilera, et al.
Published: (2022-11-01) -
A monoamine oxidase B inhibitor ethyl ferulate suppresses microglia-mediated neuroinflammation and alleviates ischemic brain injury
by: Xinxin Zou, et al.
Published: (2022-10-01) -
Development of morpholine ring-bearing halogenated α,β-unsaturated ketones as selective monoamine oxidase-B inhibitors
by: Jiseong Lee, et al.
Published: (2024-01-01) -
Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach
by: Aathira Sujathan Nair, et al.
Published: (2021-05-01) -
Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson’s Disease
by: Amritha Manoharan, et al.
Published: (2023-08-01)